New indications of SGLT2-inhibitorsJadoul, Michel(2022) 17e Congrès UCLouvain d’Endocrino-Diabétologie — Location: UCL (4.October.2022)
Files265854.pdf Open Access Adobe PDF91.86 KBDownloadDetailsAuthorsJadoul, MichelUCLouvainAuthorAffiliationsUCLouvainSSS/IREC/NEFR - Pôle de NéphrologieUCLouvain(SLuc) Service de néphrologieShow moreCitations APA Chicago FWB Jadoul, M. (2022). New indications of SGLT2-inhibitors. Louvain médical, 141(7), 365-368. https://hdl.handle.net/2078.5/101705 (Original work published 2022)